Identity
- Trade Name
- PU YUAN FDA UDI
- Generic Name
- Eye splash shield, single-use FDA UDI
- Device Name
- Anti-splash diaphragm FDA UDI
- Model / Reference
- SB2F-PEELAWAY FDA UDI
- Description
- Anti-splash diaphragm FDA UDI
Identifiers
- Primary DI / UDI-DI
- 06921825700781 FDA UDI
- FDA Product Code
- HOY FDA UDI
- GMDN Term
- Eye splash shield, single-use FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 886.4750 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Eye splash shield, single-use
Pu Yuan by Guangzhou Fuzelong Hygiene Material Co., Ltd. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Eye splash shield, single-use.
- TIDIShield — TIDI PRODUCTS, LLC · Class I
- MediChoice — OWENS & MINOR DISTRIBUTION, INC. · Class I
- SHIELDMATE — ALPHAPROTECH, INC. · Class II
- TIDI — TIDI PRODUCTS, LLC · Class I
- RHINO RESCUE — Wuxi Emsrun Technology Co., Ltd. · Class I
- Medline — MEDLINE INDUSTRIES, INC. · Class II
- CARDINAL HEALTH — Cardinal Health 200, LLC · Class I
- DeRoyal — DEROYAL INDUSTRIES, INC. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Guangzhou Fuzelong Hygiene Material Co., Ltd.
Sources (1)
- FDA UDI 9c61b40f-746a-4a55-b55b-798a8c866d37 35 fields · synced May 30, 2026